Global Microarray-based Non-Invasive Prenatal Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Microarray-based Non-Invasive Prenatal Testing market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
For expectant mothers, microarray-based non-invasive prenatal testing (NIPT) provides a secure and educational screening choice. To determine the likelihood of chromosomal abnormalities in the foetus, it examines cell-free foetal DNA that is circulating in the mother's blood. In contrast to conventional techniques that may result in miscarriage, NIPT is a blood test. With a detection rate for Down syndrome that is above 99%, this extremely reliable test yields findings in less than a week. In comparison to earlier techniques, it can even test for a wider spectrum of disorders. However, NIPT is only a screening tool and not a conclusive diagnosis. It could require more testing to be confirmed. It might not be appropriate for all pregnancies, and the cost and insurance coverage can differ.
This report is a detailed and comprehensive analysis for global Microarray-based Non-Invasive Prenatal Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
For expectant mothers, microarray-based non-invasive prenatal testing (NIPT) provides a secure and educational screening choice. To determine the likelihood of chromosomal abnormalities in the foetus, it examines cell-free foetal DNA that is circulating in the mother's blood. In contrast to conventional techniques that may result in miscarriage, NIPT is a blood test. With a detection rate for Down syndrome that is above 99%, this extremely reliable test yields findings in less than a week. In comparison to earlier techniques, it can even test for a wider spectrum of disorders. However, NIPT is only a screening tool and not a conclusive diagnosis. It could require more testing to be confirmed. It might not be appropriate for all pregnancies, and the cost and insurance coverage can differ.
This report is a detailed and comprehensive analysis for global Microarray-based Non-Invasive Prenatal Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
- Global Microarray-based Non-Invasive Prenatal Testing market size and forecasts, in consumption value ($ Million), 2021-2032
- Global Microarray-based Non-Invasive Prenatal Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
- Global Microarray-based Non-Invasive Prenatal Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
- Global Microarray-based Non-Invasive Prenatal Testing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Microarray-based Non-Invasive Prenatal Testing
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
- This report profiles key players in the global Microarray-based Non-Invasive Prenatal Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Ariosa Diagnostics (Roche), BGI Group, Eurofins LifeCodexx GmbH, Illumina, Laboratory Corporation of America, Myriad Genetics, Natera, PerkinElmer Inc, Quest Diagnostics, etc.
- This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Microarray-based Non-Invasive Prenatal Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- Trisomy Detection
- Microdeletion Syndromes
- Other
Market segment by Application
- Hospitals & Clinics
- Independent Laboratories
Market segment by players, this report covers
- Agilent Technologies
- Ariosa Diagnostics (Roche)
- BGI Group
- Eurofins LifeCodexx GmbH
- Illumina
- Laboratory Corporation of America
- Myriad Genetics
- Natera
- PerkinElmer Inc
- Quest Diagnostics
- Sequenom
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
- Chapter 1, to describe Microarray-based Non-Invasive Prenatal Testing product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top players of Microarray-based Non-Invasive Prenatal Testing, with revenue, gross margin, and global market share of Microarray-based Non-Invasive Prenatal Testing from 2021 to 2026.
- Chapter 3, the Microarray-based Non-Invasive Prenatal Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
- Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Microarray-based Non-Invasive Prenatal Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
- Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
- Chapter 12, the key raw materials and key suppliers, and industry chain of Microarray-based Non-Invasive Prenatal Testing.
- Chapter 13, to describe Microarray-based Non-Invasive Prenatal Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Microarray-based Non-Invasive Prenatal Testing by Type
1.3.1 Overview: Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type in 2025
1.3.3 Trisomy Detection
1.3.4 Microdeletion Syndromes
1.3.5 Other
1.4 Global Microarray-based Non-Invasive Prenatal Testing Market by Application
1.4.1 Overview: Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospitals & Clinics
1.4.3 Independent Laboratories
1.5 Global Microarray-based Non-Invasive Prenatal Testing Market Size & Forecast
1.6 Global Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast by Region
1.6.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region, (2021-2032)
1.6.3 North America Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
1.6.4 Europe Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
1.6.6 South America Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business
2.1.3 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.1.4 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Agilent Technologies Recent Developments and Future Plans
2.2 Ariosa Diagnostics (Roche)
2.2.1 Ariosa Diagnostics (Roche) Details
2.2.2 Ariosa Diagnostics (Roche) Major Business
2.2.3 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.2.4 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Ariosa Diagnostics (Roche) Recent Developments and Future Plans
2.3 BGI Group
2.3.1 BGI Group Details
2.3.2 BGI Group Major Business
2.3.3 BGI Group Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.3.4 BGI Group Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 BGI Group Recent Developments and Future Plans
2.4 Eurofins LifeCodexx GmbH
2.4.1 Eurofins LifeCodexx GmbH Details
2.4.2 Eurofins LifeCodexx GmbH Major Business
2.4.3 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.4.4 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Eurofins LifeCodexx GmbH Recent Developments and Future Plans
2.5 Illumina
2.5.1 Illumina Details
2.5.2 Illumina Major Business
2.5.3 Illumina Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.5.4 Illumina Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Illumina Recent Developments and Future Plans
2.6 Laboratory Corporation of America
2.6.1 Laboratory Corporation of America Details
2.6.2 Laboratory Corporation of America Major Business
2.6.3 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.6.4 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Laboratory Corporation of America Recent Developments and Future Plans
2.7 Myriad Genetics
2.7.1 Myriad Genetics Details
2.7.2 Myriad Genetics Major Business
2.7.3 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.7.4 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Myriad Genetics Recent Developments and Future Plans
2.8 Natera
2.8.1 Natera Details
2.8.2 Natera Major Business
2.8.3 Natera Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.8.4 Natera Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Natera Recent Developments and Future Plans
2.9 PerkinElmer Inc
2.9.1 PerkinElmer Inc Details
2.9.2 PerkinElmer Inc Major Business
2.9.3 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.9.4 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 PerkinElmer Inc Recent Developments and Future Plans
2.10 Quest Diagnostics
2.10.1 Quest Diagnostics Details
2.10.2 Quest Diagnostics Major Business
2.10.3 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.10.4 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Quest Diagnostics Recent Developments and Future Plans
2.11 Sequenom
2.11.1 Sequenom Details
2.11.2 Sequenom Major Business
2.11.3 Sequenom Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.11.4 Sequenom Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Sequenom Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Microarray-based Non-Invasive Prenatal Testing Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Microarray-based Non-Invasive Prenatal Testing by Company Revenue
3.2.2 Top 3 Microarray-based Non-Invasive Prenatal Testing Players Market Share in 2025
3.2.3 Top 6 Microarray-based Non-Invasive Prenatal Testing Players Market Share in 2025
3.3 Microarray-based Non-Invasive Prenatal Testing Market: Overall Company Footprint Analysis
3.3.1 Microarray-based Non-Invasive Prenatal Testing Market: Region Footprint
3.3.2 Microarray-based Non-Invasive Prenatal Testing Market: Company Product Type Footprint
3.3.3 Microarray-based Non-Invasive Prenatal Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Microarray-based Non-Invasive Prenatal Testing Consumption Value and Market Share by Type (2021-2026)
4.2 Global Microarray-based Non-Invasive Prenatal Testing Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application (2021-2026)
5.2 Global Microarray-based Non-Invasive Prenatal Testing Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
6.2 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2032)
6.3 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country
6.3.1 North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2032)
6.3.2 United States Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
6.3.3 Canada Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
6.3.4 Mexico Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
7.2 Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2032)
7.3 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country
7.3.1 Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2032)
7.3.2 Germany Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
7.3.3 France Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
7.3.5 Russia Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
7.3.6 Italy Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region
8.3.1 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Region (2021-2032)
8.3.2 China Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
8.3.3 Japan Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
8.3.4 South Korea Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
8.3.5 India Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
8.3.7 Australia Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
9.2 South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2032)
9.3 South America Microarray-based Non-Invasive Prenatal Testing Market Size by Country
9.3.1 South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2032)
9.3.2 Brazil Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
9.3.3 Argentina Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country
10.3.1 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2032)
10.3.2 Turkey Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
10.3.4 UAE Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Microarray-based Non-Invasive Prenatal Testing Market Drivers
11.2 Microarray-based Non-Invasive Prenatal Testing Market Restraints
11.3 Microarray-based Non-Invasive Prenatal Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Microarray-based Non-Invasive Prenatal Testing Industry Chain
12.2 Microarray-based Non-Invasive Prenatal Testing Upstream Analysis
12.3 Microarray-based Non-Invasive Prenatal Testing Midstream Analysis
12.4 Microarray-based Non-Invasive Prenatal Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Microarray-based Non-Invasive Prenatal Testing by Type
1.3.1 Overview: Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type in 2025
1.3.3 Trisomy Detection
1.3.4 Microdeletion Syndromes
1.3.5 Other
1.4 Global Microarray-based Non-Invasive Prenatal Testing Market by Application
1.4.1 Overview: Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospitals & Clinics
1.4.3 Independent Laboratories
1.5 Global Microarray-based Non-Invasive Prenatal Testing Market Size & Forecast
1.6 Global Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast by Region
1.6.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region, (2021-2032)
1.6.3 North America Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
1.6.4 Europe Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
1.6.6 South America Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business
2.1.3 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.1.4 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Agilent Technologies Recent Developments and Future Plans
2.2 Ariosa Diagnostics (Roche)
2.2.1 Ariosa Diagnostics (Roche) Details
2.2.2 Ariosa Diagnostics (Roche) Major Business
2.2.3 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.2.4 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Ariosa Diagnostics (Roche) Recent Developments and Future Plans
2.3 BGI Group
2.3.1 BGI Group Details
2.3.2 BGI Group Major Business
2.3.3 BGI Group Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.3.4 BGI Group Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 BGI Group Recent Developments and Future Plans
2.4 Eurofins LifeCodexx GmbH
2.4.1 Eurofins LifeCodexx GmbH Details
2.4.2 Eurofins LifeCodexx GmbH Major Business
2.4.3 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.4.4 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Eurofins LifeCodexx GmbH Recent Developments and Future Plans
2.5 Illumina
2.5.1 Illumina Details
2.5.2 Illumina Major Business
2.5.3 Illumina Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.5.4 Illumina Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Illumina Recent Developments and Future Plans
2.6 Laboratory Corporation of America
2.6.1 Laboratory Corporation of America Details
2.6.2 Laboratory Corporation of America Major Business
2.6.3 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.6.4 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Laboratory Corporation of America Recent Developments and Future Plans
2.7 Myriad Genetics
2.7.1 Myriad Genetics Details
2.7.2 Myriad Genetics Major Business
2.7.3 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.7.4 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Myriad Genetics Recent Developments and Future Plans
2.8 Natera
2.8.1 Natera Details
2.8.2 Natera Major Business
2.8.3 Natera Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.8.4 Natera Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Natera Recent Developments and Future Plans
2.9 PerkinElmer Inc
2.9.1 PerkinElmer Inc Details
2.9.2 PerkinElmer Inc Major Business
2.9.3 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.9.4 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 PerkinElmer Inc Recent Developments and Future Plans
2.10 Quest Diagnostics
2.10.1 Quest Diagnostics Details
2.10.2 Quest Diagnostics Major Business
2.10.3 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.10.4 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Quest Diagnostics Recent Developments and Future Plans
2.11 Sequenom
2.11.1 Sequenom Details
2.11.2 Sequenom Major Business
2.11.3 Sequenom Microarray-based Non-Invasive Prenatal Testing Product and Solutions
2.11.4 Sequenom Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Sequenom Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Microarray-based Non-Invasive Prenatal Testing Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Microarray-based Non-Invasive Prenatal Testing by Company Revenue
3.2.2 Top 3 Microarray-based Non-Invasive Prenatal Testing Players Market Share in 2025
3.2.3 Top 6 Microarray-based Non-Invasive Prenatal Testing Players Market Share in 2025
3.3 Microarray-based Non-Invasive Prenatal Testing Market: Overall Company Footprint Analysis
3.3.1 Microarray-based Non-Invasive Prenatal Testing Market: Region Footprint
3.3.2 Microarray-based Non-Invasive Prenatal Testing Market: Company Product Type Footprint
3.3.3 Microarray-based Non-Invasive Prenatal Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Microarray-based Non-Invasive Prenatal Testing Consumption Value and Market Share by Type (2021-2026)
4.2 Global Microarray-based Non-Invasive Prenatal Testing Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application (2021-2026)
5.2 Global Microarray-based Non-Invasive Prenatal Testing Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
6.2 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2032)
6.3 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country
6.3.1 North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2032)
6.3.2 United States Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
6.3.3 Canada Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
6.3.4 Mexico Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
7.2 Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2032)
7.3 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country
7.3.1 Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2032)
7.3.2 Germany Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
7.3.3 France Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
7.3.5 Russia Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
7.3.6 Italy Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region
8.3.1 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Region (2021-2032)
8.3.2 China Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
8.3.3 Japan Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
8.3.4 South Korea Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
8.3.5 India Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
8.3.7 Australia Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
9.2 South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2032)
9.3 South America Microarray-based Non-Invasive Prenatal Testing Market Size by Country
9.3.1 South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2032)
9.3.2 Brazil Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
9.3.3 Argentina Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country
10.3.1 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2032)
10.3.2 Turkey Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
10.3.4 UAE Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Microarray-based Non-Invasive Prenatal Testing Market Drivers
11.2 Microarray-based Non-Invasive Prenatal Testing Market Restraints
11.3 Microarray-based Non-Invasive Prenatal Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Microarray-based Non-Invasive Prenatal Testing Industry Chain
12.2 Microarray-based Non-Invasive Prenatal Testing Upstream Analysis
12.3 Microarray-based Non-Invasive Prenatal Testing Midstream Analysis
12.4 Microarray-based Non-Invasive Prenatal Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies Major Business
Table 7. Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 8. Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Agilent Technologies Recent Developments and Future Plans
Table 10. Ariosa Diagnostics (Roche) Company Information, Head Office, and Major Competitors
Table 11. Ariosa Diagnostics (Roche) Major Business
Table 12. Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 13. Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Ariosa Diagnostics (Roche) Recent Developments and Future Plans
Table 15. BGI Group Company Information, Head Office, and Major Competitors
Table 16. BGI Group Major Business
Table 17. BGI Group Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 18. BGI Group Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Eurofins LifeCodexx GmbH Company Information, Head Office, and Major Competitors
Table 20. Eurofins LifeCodexx GmbH Major Business
Table 21. Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 22. Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Eurofins LifeCodexx GmbH Recent Developments and Future Plans
Table 24. Illumina Company Information, Head Office, and Major Competitors
Table 25. Illumina Major Business
Table 26. Illumina Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 27. Illumina Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Illumina Recent Developments and Future Plans
Table 29. Laboratory Corporation of America Company Information, Head Office, and Major Competitors
Table 30. Laboratory Corporation of America Major Business
Table 31. Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 32. Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Laboratory Corporation of America Recent Developments and Future Plans
Table 34. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 35. Myriad Genetics Major Business
Table 36. Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 37. Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Myriad Genetics Recent Developments and Future Plans
Table 39. Natera Company Information, Head Office, and Major Competitors
Table 40. Natera Major Business
Table 41. Natera Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 42. Natera Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Natera Recent Developments and Future Plans
Table 44. PerkinElmer Inc Company Information, Head Office, and Major Competitors
Table 45. PerkinElmer Inc Major Business
Table 46. PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 47. PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. PerkinElmer Inc Recent Developments and Future Plans
Table 49. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 50. Quest Diagnostics Major Business
Table 51. Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 52. Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Quest Diagnostics Recent Developments and Future Plans
Table 54. Sequenom Company Information, Head Office, and Major Competitors
Table 55. Sequenom Major Business
Table 56. Sequenom Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 57. Sequenom Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Sequenom Recent Developments and Future Plans
Table 59. Global Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million) by Players (2021-2026)
Table 60. Global Microarray-based Non-Invasive Prenatal Testing Revenue Share by Players (2021-2026)
Table 61. Breakdown of Microarray-based Non-Invasive Prenatal Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 62. Market Position of Players in Microarray-based Non-Invasive Prenatal Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 63. Head Office of Key Microarray-based Non-Invasive Prenatal Testing Players
Table 64. Microarray-based Non-Invasive Prenatal Testing Market: Company Product Type Footprint
Table 65. Microarray-based Non-Invasive Prenatal Testing Market: Company Product Application Footprint
Table 66. Microarray-based Non-Invasive Prenatal Testing New Market Entrants and Barriers to Market Entry
Table 67. Microarray-based Non-Invasive Prenatal Testing Mergers, Acquisition, Agreements, and Collaborations
Table 68. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value (USD Million) by Type (2021-2026)
Table 69. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Share by Type (2021-2026)
Table 70. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Forecast by Type (2027-2032)
Table 71. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2026)
Table 72. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Forecast by Application (2027-2032)
Table 73. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 74. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 75. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 76. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 77. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 78. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 80. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 81. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 82. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 83. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 84. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 85. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 86. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 87. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 88. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 89. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Region (2027-2032) & (USD Million)
Table 91. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 92. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 93. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 94. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 95. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 96. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 98. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 99. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 100. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 101. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 103. Global Key Players of Microarray-based Non-Invasive Prenatal Testing Upstream (Raw Materials)
Table 104. Global Microarray-based Non-Invasive Prenatal Testing Typical Customers
Table 1. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies Major Business
Table 7. Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 8. Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Agilent Technologies Recent Developments and Future Plans
Table 10. Ariosa Diagnostics (Roche) Company Information, Head Office, and Major Competitors
Table 11. Ariosa Diagnostics (Roche) Major Business
Table 12. Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 13. Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Ariosa Diagnostics (Roche) Recent Developments and Future Plans
Table 15. BGI Group Company Information, Head Office, and Major Competitors
Table 16. BGI Group Major Business
Table 17. BGI Group Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 18. BGI Group Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Eurofins LifeCodexx GmbH Company Information, Head Office, and Major Competitors
Table 20. Eurofins LifeCodexx GmbH Major Business
Table 21. Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 22. Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Eurofins LifeCodexx GmbH Recent Developments and Future Plans
Table 24. Illumina Company Information, Head Office, and Major Competitors
Table 25. Illumina Major Business
Table 26. Illumina Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 27. Illumina Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Illumina Recent Developments and Future Plans
Table 29. Laboratory Corporation of America Company Information, Head Office, and Major Competitors
Table 30. Laboratory Corporation of America Major Business
Table 31. Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 32. Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Laboratory Corporation of America Recent Developments and Future Plans
Table 34. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 35. Myriad Genetics Major Business
Table 36. Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 37. Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Myriad Genetics Recent Developments and Future Plans
Table 39. Natera Company Information, Head Office, and Major Competitors
Table 40. Natera Major Business
Table 41. Natera Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 42. Natera Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Natera Recent Developments and Future Plans
Table 44. PerkinElmer Inc Company Information, Head Office, and Major Competitors
Table 45. PerkinElmer Inc Major Business
Table 46. PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 47. PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. PerkinElmer Inc Recent Developments and Future Plans
Table 49. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 50. Quest Diagnostics Major Business
Table 51. Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 52. Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Quest Diagnostics Recent Developments and Future Plans
Table 54. Sequenom Company Information, Head Office, and Major Competitors
Table 55. Sequenom Major Business
Table 56. Sequenom Microarray-based Non-Invasive Prenatal Testing Product and Solutions
Table 57. Sequenom Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Sequenom Recent Developments and Future Plans
Table 59. Global Microarray-based Non-Invasive Prenatal Testing Revenue (USD Million) by Players (2021-2026)
Table 60. Global Microarray-based Non-Invasive Prenatal Testing Revenue Share by Players (2021-2026)
Table 61. Breakdown of Microarray-based Non-Invasive Prenatal Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 62. Market Position of Players in Microarray-based Non-Invasive Prenatal Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 63. Head Office of Key Microarray-based Non-Invasive Prenatal Testing Players
Table 64. Microarray-based Non-Invasive Prenatal Testing Market: Company Product Type Footprint
Table 65. Microarray-based Non-Invasive Prenatal Testing Market: Company Product Application Footprint
Table 66. Microarray-based Non-Invasive Prenatal Testing New Market Entrants and Barriers to Market Entry
Table 67. Microarray-based Non-Invasive Prenatal Testing Mergers, Acquisition, Agreements, and Collaborations
Table 68. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value (USD Million) by Type (2021-2026)
Table 69. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Share by Type (2021-2026)
Table 70. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Forecast by Type (2027-2032)
Table 71. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2026)
Table 72. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Forecast by Application (2027-2032)
Table 73. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 74. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 75. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 76. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 77. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 78. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 80. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 81. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 82. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 83. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 84. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 85. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 86. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 87. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 88. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 89. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Region (2027-2032) & (USD Million)
Table 91. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 92. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 93. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 94. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 95. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 96. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 98. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 99. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 100. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 101. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 103. Global Key Players of Microarray-based Non-Invasive Prenatal Testing Upstream (Raw Materials)
Table 104. Global Microarray-based Non-Invasive Prenatal Testing Typical Customers
LIST OF FIGURES
Figure 1. Microarray-based Non-Invasive Prenatal Testing Picture
Figure 2. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type in 2025
Figure 4. Trisomy Detection
Figure 5. Microdeletion Syndromes
Figure 6. Other
Figure 7. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application in 2025
Figure 9. Hospitals & Clinics Picture
Figure 10. Independent Laboratories Picture
Figure 11. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Market Microarray-based Non-Invasive Prenatal Testing Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 14. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Region (2021-2032)
Figure 15. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Region in 2025
Figure 16. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 17. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 18. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 19. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 20. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Microarray-based Non-Invasive Prenatal Testing Revenue Share by Players in 2025
Figure 23. Microarray-based Non-Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 24. Market Share of Microarray-based Non-Invasive Prenatal Testing by Player Revenue in 2025
Figure 25. Top 3 Microarray-based Non-Invasive Prenatal Testing Players Market Share in 2025
Figure 26. Top 6 Microarray-based Non-Invasive Prenatal Testing Players Market Share in 2025
Figure 27. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Share by Type (2021-2026)
Figure 28. Global Microarray-based Non-Invasive Prenatal Testing Market Share Forecast by Type (2027-2032)
Figure 29. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Share by Application (2021-2026)
Figure 30. Global Microarray-based Non-Invasive Prenatal Testing Market Share Forecast by Application (2027-2032)
Figure 31. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type (2021-2032)
Figure 32. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application (2021-2032)
Figure 33. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Country (2021-2032)
Figure 34. United States Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 35. Canada Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 36. Mexico Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type (2021-2032)
Figure 38. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application (2021-2032)
Figure 39. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Country (2021-2032)
Figure 40. Germany Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 41. France Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 42. United Kingdom Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 43. Russia Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 44. Italy Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 45. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type (2021-2032)
Figure 46. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application (2021-2032)
Figure 47. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Region (2021-2032)
Figure 48. China Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 49. Japan Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 50. South Korea Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 51. India Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 52. Southeast Asia Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 53. Australia Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 54. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type (2021-2032)
Figure 55. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application (2021-2032)
Figure 56. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Country (2021-2032)
Figure 57. Brazil Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 58. Argentina Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 59. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type (2021-2032)
Figure 60. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application (2021-2032)
Figure 61. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Country (2021-2032)
Figure 62. Turkey Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 63. Saudi Arabia Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 64. UAE Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 65. Microarray-based Non-Invasive Prenatal Testing Market Drivers
Figure 66. Microarray-based Non-Invasive Prenatal Testing Market Restraints
Figure 67. Microarray-based Non-Invasive Prenatal Testing Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Microarray-based Non-Invasive Prenatal Testing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Microarray-based Non-Invasive Prenatal Testing Picture
Figure 2. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type in 2025
Figure 4. Trisomy Detection
Figure 5. Microdeletion Syndromes
Figure 6. Other
Figure 7. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application in 2025
Figure 9. Hospitals & Clinics Picture
Figure 10. Independent Laboratories Picture
Figure 11. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Market Microarray-based Non-Invasive Prenatal Testing Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 14. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Region (2021-2032)
Figure 15. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Region in 2025
Figure 16. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 17. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 18. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 19. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 20. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Microarray-based Non-Invasive Prenatal Testing Revenue Share by Players in 2025
Figure 23. Microarray-based Non-Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 24. Market Share of Microarray-based Non-Invasive Prenatal Testing by Player Revenue in 2025
Figure 25. Top 3 Microarray-based Non-Invasive Prenatal Testing Players Market Share in 2025
Figure 26. Top 6 Microarray-based Non-Invasive Prenatal Testing Players Market Share in 2025
Figure 27. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Share by Type (2021-2026)
Figure 28. Global Microarray-based Non-Invasive Prenatal Testing Market Share Forecast by Type (2027-2032)
Figure 29. Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Share by Application (2021-2026)
Figure 30. Global Microarray-based Non-Invasive Prenatal Testing Market Share Forecast by Application (2027-2032)
Figure 31. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type (2021-2032)
Figure 32. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application (2021-2032)
Figure 33. North America Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Country (2021-2032)
Figure 34. United States Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 35. Canada Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 36. Mexico Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type (2021-2032)
Figure 38. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application (2021-2032)
Figure 39. Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Country (2021-2032)
Figure 40. Germany Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 41. France Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 42. United Kingdom Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 43. Russia Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 44. Italy Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 45. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type (2021-2032)
Figure 46. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application (2021-2032)
Figure 47. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Region (2021-2032)
Figure 48. China Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 49. Japan Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 50. South Korea Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 51. India Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 52. Southeast Asia Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 53. Australia Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 54. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type (2021-2032)
Figure 55. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application (2021-2032)
Figure 56. South America Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Country (2021-2032)
Figure 57. Brazil Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 58. Argentina Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 59. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type (2021-2032)
Figure 60. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application (2021-2032)
Figure 61. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Country (2021-2032)
Figure 62. Turkey Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 63. Saudi Arabia Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 64. UAE Microarray-based Non-Invasive Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 65. Microarray-based Non-Invasive Prenatal Testing Market Drivers
Figure 66. Microarray-based Non-Invasive Prenatal Testing Market Restraints
Figure 67. Microarray-based Non-Invasive Prenatal Testing Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Microarray-based Non-Invasive Prenatal Testing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
